The Conflicts Committee engaged Potter Anderson & Corroon LLP as its legal advisor and Evercore as its financial advisor. Gibson, Dunn & Crutcher LLP assisted Evercore....
Sisecam Chemicals Wyoming LLC’s Acquisition of Sisecam Resources LP
Clarion Capital’s Majority Stake Acquisition in Vin Di Bona Productions and Fishbowl Worldwide Media
Paul Hastings LLP advised Clarion Capital on the deal. Willkie Farr & Gallagher advised John Stevens and Hans Schiff. Vin Di Bona has sold a majority...
Stone Point Capital’s Investment In IEQ Capital
Paul Hastings advised IEQ Capital on the deal while Sidley represented Stone Point. IEQ Capital, LLC (“IEQ”), a leading independent wealth management firm and alternative investment...
Progress’ $355 Million Acquisition of MarkLogic
Paul Hastings LLP advised Vector Capital on the deal. Progress (NASDAQ: PRGS), the trusted provider of application development and infrastructure software, announced it has entered into...
TheSoul Publishing’s Majority Stake Acquisition in Underscore Talent
Paul Hastings LLP advised Underscore Talent on the deal. Underscore Talent, a leading next-generation management company that helps creator economy talent, announced the sale of a majority...
HyperloopTT’s Business Combination with Forest Road Acquisition Corporation II
Paul Hastings LLP advised Hyperloop Transportation Technologies on the deal. Hyperloop Transportation Technologies, a leading transportation and technology licensing company focused on realizing the hyperloop, and...
Prize’s Business Combination with Rose Hill Acquisition Corporation
Paul Hastings LLP and Cariola, Díez, Pérez-Cotapos advised Prize on the deal. Greenberg Traurig and EY Law – Chile advised Rose Hill Acquisition Corp. Rose Hill...
Digital Transformation Opportunities Corp.’s Business Combination with the American Oncology Network
Paul Hastings LLP is advising Digital Transformation Opportunities Corp. (DTOC) on the deal. Digital Transformation Opportunities Corp. (DTOC), a publicly traded SPAC, announced its business combination with...
Orchestra BioMed’s $110 Million Series D Financing
Paul Hastings LLP advised Orchestra BioMed on the deal. Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced the closing of a $110...
Orchestra BioMed’s Collaboration with Medtronic
Paul Hastings LLP advised Orchestra BioMed on the deal. Orchestra BioMed announced a strategic collaboration with Medtronic to develop Orchestra BioMed’s BackBeat Cardiac Neuromodulation Therapy™ (CNT™) as...
Symphony Technology Group’s Acquisition of eProductivity Software
Paul Hastings advised Symphony Technology Group on the deal. Symphony Technology Group, a private equity firm specializing in partnering with market leading companies in data, software,...
CM Group’s Merger with Cheetah Digital
Paul Hastings advised Vector Capital and its portfolio company, Cheetah Digital on the deal. Willkie Farr & Gallagher advised CM Group. Vector Capital announced the merger between Cheetah...